Category : Science and TechPublished on: August 02 2024
Share on facebook
Sinergium Biotech, supported by WHO and MPP, is leading an initiative to develop mRNA vaccines for avian influenza (H5N1), aiming to enhance pandemic preparedness in low- and middle-income
The project will focus on preclinical development and intends to share technology and expertise worldwide, promoting equitable access and fostering international collaboration.